| Grayling Nursing & Rehab Community | |
| 331 Meadows Drive, Grayling, Michigan 49738 | |
| (989) 348-2801 | |
| Name | Grayling Nursing & Rehab Community |
|---|---|
| Location | 331 Meadows Drive, Grayling, Michigan |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 72 |
| Occupancy Rate | 70.97% |
| Medicare ID (CCN) | 235432 |
| Legal Business Name | Atrium Grayling, Llc. |
| Ownership Type | For Profit - Individual |
| NPI Number | 1851399927 |
| Organization Name | ATRIUM GRAYLING LLC |
| Doing Business As | GRAYLING NURSING AND REHABILITATION COMMUNITY |
| Address | 331 Meadows Dr, Grayling, MI 49738 |
| Phone Number | 989-348-2801 |
News Archive
A team of researchers from the National University of Singapore (NUS) has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
When Kayla Kjelshus gave birth to her first child, the infant spent seven days in the neonatal intensive care unit, known as the NICU.
Biovail Corporation today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd. According to Teva, the trial is intended to address reports of inefficacy and adverse events by consumers who switched from Wellbutrin XL® 300 mg, Biovail's FDA-approved brand of the antidepressant, bupropion hydrochloride, to Budeprion XL, Teva's generic formulation of the drug. The trial was described in a Dow Jones Newswire article dated December 2, 2009.
Photodynamic diagnosis using 5-aminolevulinic acid (5-ALA) is now widely used for neurosurgical resection of brain tumors.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A team of researchers from the National University of Singapore (NUS) has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
When Kayla Kjelshus gave birth to her first child, the infant spent seven days in the neonatal intensive care unit, known as the NICU.
Biovail Corporation today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd. According to Teva, the trial is intended to address reports of inefficacy and adverse events by consumers who switched from Wellbutrin XL® 300 mg, Biovail's FDA-approved brand of the antidepressant, bupropion hydrochloride, to Budeprion XL, Teva's generic formulation of the drug. The trial was described in a Dow Jones Newswire article dated December 2, 2009.
Photodynamic diagnosis using 5-aminolevulinic acid (5-ALA) is now widely used for neurosurgical resection of brain tumors.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 8.81 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.63 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 18.95 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.64 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.61 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.4 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 11.98 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.33 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.44 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 1.59 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.2 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.48 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 77.93 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.96 | 82.93 |
News Archive
A team of researchers from the National University of Singapore (NUS) has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
When Kayla Kjelshus gave birth to her first child, the infant spent seven days in the neonatal intensive care unit, known as the NICU.
Biovail Corporation today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd. According to Teva, the trial is intended to address reports of inefficacy and adverse events by consumers who switched from Wellbutrin XL® 300 mg, Biovail's FDA-approved brand of the antidepressant, bupropion hydrochloride, to Budeprion XL, Teva's generic formulation of the drug. The trial was described in a Dow Jones Newswire article dated December 2, 2009.
Photodynamic diagnosis using 5-aminolevulinic acid (5-ALA) is now widely used for neurosurgical resection of brain tumors.
› Verified 1 days ago
Munson Healthcare Crawford Continuing Care Center Location: 1100 Michigan Ave, Grayling, Michigan 49738 Phone: (989) 348-0317 | |
Grayling Nursing & Rehab Community Location: 331 Meadows Drive, Grayling, Michigan 49738 Phone: (989) 348-2801 |